AP707

· Apurano Pharmaceuticals GmbH

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for AP707, covering 2024-01-31 to 2024-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Back Pain [Phase 3]